<?xml version="1.0" encoding="UTF-8" ?>
    
    <urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
            <url>
                <loc>https://investor.cellimpact.com/</loc>
                <lastmod>2026-03-20T07:44:21&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                <priority>0.5</priority>
            </url>
                <url>
                    <loc>https://investor.cellimpact.com/om-oss/</loc>
                    <lastmod>2026-02-04T07:58:54&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/om-oss/vision-och-affaerside/</loc>
                    <lastmod>2026-03-20T13:59:29&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/om-oss/marknad-och-kunder/</loc>
                    <lastmod>2026-03-25T15:44:47&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/om-oss/marknad-och-kunder/marknadsutblick/</loc>
                    <lastmod>2026-03-23T09:22:03&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/om-oss/marknad-och-kunder/vaetgasindustrins-drivkrafter/</loc>
                    <lastmod>2026-03-23T09:27:23&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/om-oss/affaersmodell/</loc>
                    <lastmod>2026-03-20T14:01:38&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/om-oss/affaersmodell/vaerdekedja/</loc>
                    <lastmod>2026-03-23T09:14:37&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/om-oss/affaersmodell/vaara-produkter-och-tjaenster/</loc>
                    <lastmod>2023-06-27T09:51:28&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/om-oss/affaersmodell/vaara-kunder/</loc>
                    <lastmod>2025-08-26T09:16:24&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/om-oss/affaersmodell/kundresan/</loc>
                    <lastmod>2023-06-27T09:54:30&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/om-oss/strategi/</loc>
                    <lastmod>2023-06-27T10:24:35&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/om-oss/strategi/haallbarhetsmaal/</loc>
                    <lastmod>2026-03-25T15:50:10&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/om-oss/strategi/finansiella-maal/</loc>
                    <lastmod>2024-10-09T11:31:47&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/om-oss/vd-ord/</loc>
                    <lastmod>2026-03-20T13:36:55&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/om-oss/historik/</loc>
                    <lastmod>2026-02-04T08:18:40&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/bolagsstyrning/</loc>
                    <lastmod>2026-03-25T15:53:53&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/bolagsstyrning/bolagsordning/</loc>
                    <lastmod>2025-08-28T06:17:11&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/bolagsstyrning/bolagsstaemmor/</loc>
                    <lastmod>2026-03-20T07:17:21&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/bolagsstyrning/valberedning/</loc>
                    <lastmod>2025-10-17T13:34:50&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/bolagsstyrning/styrelse/</loc>
                    <lastmod>2025-04-25T08:40:16&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/bolagsstyrning/ledning/</loc>
                    <lastmod>2025-06-17T11:22:21&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/bolagsstyrning/revisor/</loc>
                    <lastmod>2023-06-26T08:14:04&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/bolagsstyrning/incitamentsprogram/</loc>
                    <lastmod>2025-10-07T14:50:24&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/</loc>
                    <lastmod>2026-03-20T07:45:09&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/anledningar-att-investera-i-cell-impact/</loc>
                    <lastmod>2025-06-26T09:20:34&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/rapporter-och-presentationer/</loc>
                    <lastmod>2023-06-26T08:20:54&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/</loc>
                    <lastmod>2023-06-26T08:21:07&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2023-03-24-2022-arsredovisning/</loc>
                    <lastmod>2023-06-19T11:48:23&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2023-04-20-2023-arsstaemma/</loc>
                    <lastmod>2023-06-19T11:47:54&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2023-05-10-2023-q1-delaarsrapport/</loc>
                    <lastmod>2023-06-19T11:48:06&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2023-10-24-2023-q2-delaarsrapport/</loc>
                    <lastmod>2023-06-26T11:47:40&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2023-11-03-2023-q3-delaarsrapport/</loc>
                    <lastmod>2023-06-19T11:48:51&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2024-02-16-2023-q4-bokslutskommunike/</loc>
                    <lastmod>2023-06-19T11:48:59&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2022-08-25-2022-q2-delaarsrapport/</loc>
                    <lastmod>2023-06-19T11:48:36&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2022-11-04-2022-q3-delaarsrapport/</loc>
                    <lastmod>2023-06-19T11:47:01&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2023-02-17-2022-q4-bokslutskommunike/</loc>
                    <lastmod>2023-06-19T11:47:45&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2022-05-06-2022-q1-delaarsrapport/</loc>
                    <lastmod>2023-06-19T11:47:26&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2023-11-03-extra-bolagsstaemma-i-cell-impact-ab/</loc>
                    <lastmod>2023-10-20T09:22:48&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2024-03-22-2023-arsredovisning/</loc>
                    <lastmod>2024-01-15T14:02:49&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2024-05-14-2024-q1-delaarsrapport/</loc>
                    <lastmod>2024-05-14T04:24:02&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2024-08-23-2024-q2-delaarsrapport/</loc>
                    <lastmod>2024-01-17T12:49:46&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2024-11-06-2024-q3-delaarsrapport/</loc>
                    <lastmod>2024-01-17T12:50:42&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2025-02-14-2024-q4-bokslutskommunike/</loc>
                    <lastmod>2024-01-17T12:51:41&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2025-03-20-2024-arsredovisning/</loc>
                    <lastmod>2024-01-17T12:52:46&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2025-04-24-2025-arsstaemma/</loc>
                    <lastmod>2024-01-17T12:53:50&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2024-04-25-2024-arsstaemma/</loc>
                    <lastmod>2024-01-17T13:05:28&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2024-09-16-sista-dag-foer-handel-to2/</loc>
                    <lastmod>2024-09-16T06:26:35&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2025-05-14-2025-q1-delaarsrapport/</loc>
                    <lastmod>2025-01-29T09:27:56&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2025-08-22-2025-q2-delaarsrapport/</loc>
                    <lastmod>2025-01-29T09:32:12&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2025-11-06-2025-q3-delaarsrapport/</loc>
                    <lastmod>2025-01-29T09:34:43&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2026-02-04-2025-q4-bokslutskommunike/</loc>
                    <lastmod>2026-01-20T07:03:53&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2026-03-20-2025-arsredovisning/</loc>
                    <lastmod>2025-01-29T09:37:05&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2026-04-23-2026-arsstaemma/</loc>
                    <lastmod>2025-01-29T09:38:58&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2025-06-19-extra-bolagsstaemma-i-cell-impact-ab/</loc>
                    <lastmod>2025-05-20T07:59:27&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2025-08-22-sista-dag-foer-handel-i-bolagets-aktie-innan-sammanlaeggningen/</loc>
                    <lastmod>2025-08-18T12:51:55&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2025-08-25-foersta-dag-foer-handel-i-bolagets-aktie-efter-sammanlaeggningen/</loc>
                    <lastmod>2025-08-18T12:52:34&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2025-08-26-avstaemningsdag-foer-sammanlaeggningen/</loc>
                    <lastmod>2025-08-18T12:53:00&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2025-08-27-det-nya-antalet-aktier-foervaentas-registreras-i-euroclearsystemet/</loc>
                    <lastmod>2025-08-18T12:53:27&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2026-01-30-extra-bolagsstaemma-i-cell-impact-ab/</loc>
                    <lastmod>2025-12-22T18:11:38&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2026-05-13-2026-q1-delaarsrapport/</loc>
                    <lastmod>2026-01-13T09:15:24&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2026-08-21-2026-q2-delaarsrapport/</loc>
                    <lastmod>2026-01-13T09:14:47&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2026-11-06-2026-q3-delaarsrapport/</loc>
                    <lastmod>2026-01-13T09:16:03&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2027-02-12-2026-q4-bokslutskommunike/</loc>
                    <lastmod>2026-04-14T11:49:33&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2027-04-22-2027-arsstaemma/</loc>
                    <lastmod>2026-01-13T09:17:36&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/kalender/2027-03-19-arsredovisning-2026/</loc>
                    <lastmod>2026-01-13T09:18:13&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/aktien/</loc>
                    <lastmod>2026-03-25T08:40:41&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/aktien/insynshandel/</loc>
                    <lastmod>2023-06-27T09:03:36&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/utdelning-utdelningspolicy/</loc>
                    <lastmod>2023-06-26T08:21:33&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/analytiker/</loc>
                    <lastmod>2023-06-26T08:21:44&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/risk-och-riskhantering/</loc>
                    <lastmod>2023-06-26T08:21:56&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/finansiell-information/</loc>
                    <lastmod>2026-03-20T13:24:08&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/prospekt/</loc>
                    <lastmod>2026-02-03T16:38:05&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/prospekt/foeretraedesemission-2026/</loc>
                    <lastmod>2026-02-06T09:22:00&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/prospekt/foeretraedesemission-2025/</loc>
                    <lastmod>2025-06-26T07:23:48&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/prospekt/foeretraedesemission-2023/</loc>
                    <lastmod>2025-06-24T08:25:58&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/certified-advisor/</loc>
                    <lastmod>2023-06-26T08:24:17&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/investor-relations/ir-kontakt/</loc>
                    <lastmod>2025-06-24T08:25:42&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/haallbarhet/</loc>
                    <lastmod>2026-03-23T13:54:31&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/haallbarhet/miljoemaessigt-ansvarstagande/</loc>
                    <lastmod>2026-03-25T15:07:15&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/haallbarhet/social-haallbarhet/</loc>
                    <lastmod>2026-03-25T15:23:53&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/haallbarhet/haallbar-verksamhetsstyrning/</loc>
                    <lastmod>2026-03-25T15:38:04&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/</loc>
                    <lastmod>2023-07-04T09:58:52&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/</loc>
                    <lastmod>2024-03-15T07:22:41&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-05-10-intensiv-aktivitet-och-oekat-internationellt-intresse/</loc>
                    <lastmod>2024-03-15T07:25:19&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-04-20-kommunike-fraan-aarsstaemman-2023-i-cell-impact-ab-publ/</loc>
                    <lastmod>2024-03-15T07:24:51&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-03-30-valberedningens-foerslag-till-styrelse-mm/</loc>
                    <lastmod>2024-03-15T07:25:01&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-03-27-cell-impact-anlitar-pr-byraan-solberg-foer-att-utveckla-bolagets-kommunikation-och-varumaerke/</loc>
                    <lastmod>2023-06-07T08:44:34&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-03-24-cell-impact-publicerar-aarsredovisning-foer-2022/</loc>
                    <lastmod>2024-03-15T07:24:50&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-03-20-kallelse-till-aarsstaemma-i-cell-impact-ab-publ/</loc>
                    <lastmod>2024-03-15T07:26:15&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-02-17-cell-impacts-delaarsrapport-foer-fjaerde-kvartalet-starkt-avslut-paa-aaret/</loc>
                    <lastmod>2024-03-15T07:26:15&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2022-11-18-cell-impact-aer-ett-av-sveriges-snabbast-vaexande-teknikbolag/</loc>
                    <lastmod>2024-03-15T07:26:43&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2022-11-04-cell-impact-delaarsrapport-foer-tredje-kvartalet-produkt-och-produktionsomstaellning-har-lett-till-tillfaelligt-laegre-foersaeljning/</loc>
                    <lastmod>2024-03-15T07:24:51&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2022-08-30-cell-impact-forming-demonstrationslinje-installeras-i-japan/</loc>
                    <lastmod>2024-03-15T07:26:42&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2022-08-25-cell-impact-delaarsrapport-foer-andra-kvartalet-oekad-foersaeljning-laegre-foerlust/</loc>
                    <lastmod>2024-03-15T07:24:57&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2022-06-09-cell-impact-japan-inc-faar-utvecklingsorder-paa-1-6-miljoner-sek/</loc>
                    <lastmod>2024-03-15T07:26:41&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2022-05-06-byte-av-namn-kortnamn-och-isin-kod-foer-aktierna-i-cell-impact-ab-publ/</loc>
                    <lastmod>2024-03-15T07:26:40&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2022-05-06-cell-impact-delaarsrapport-foer-foersta-kvartalet-fortsatt-hoeg-foersaeljning/</loc>
                    <lastmod>2024-03-15T07:24:56&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2022-05-05-arbetstagarrepresentant-utsedd-till-cell-impacts-styrelse/</loc>
                    <lastmod>2024-03-15T07:26:40&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2022-04-21-kommunike-fraan-aarsstaemman-2022-i-cell-impact-ab-publ/</loc>
                    <lastmod>2024-03-15T07:24:58&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2022-03-25-cell-impact-publicerar-aarsredovisning-foer-2021/</loc>
                    <lastmod>2024-03-15T07:25:00&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2022-03-22-kallelse-till-aarsstaemma-i-cell-impact-ab-publ/</loc>
                    <lastmod>2024-03-15T07:25:01&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2022-02-18-cell-impact-delaarsrapport-foer-fjaerde-kvartalet-oekad-foersaeljning/</loc>
                    <lastmod>2023-06-16T07:49:50&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-12-27-cell-impact-meddelar-slutgiltigt-utfall-av-den-fullt-garanterade-foeretraedesemissionen/</loc>
                    <lastmod>2024-03-15T07:26:38&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-12-23-cell-impacts-foeretraedesemission-aer-oevertecknad/</loc>
                    <lastmod>2024-03-15T07:26:37&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-12-06-cell-impact-offentliggoer-prospekt-avseende-foeretraedesemission/</loc>
                    <lastmod>2024-03-15T07:26:37&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-11-29-styrelsen-i-cell-impact-har-beslutat-om-en-fullt-garanterad-foeretraedesemission-om-upp-till-cirka-349-miljoner-kronor/</loc>
                    <lastmod>2024-03-15T07:26:36&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-11-18-uppdaterad-indikativ-tidplan-foer-cell-impacts-fullt-garanterade-foeretraedesemission/</loc>
                    <lastmod>2024-03-15T07:26:35&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-11-16-kommunike-fraan-extra-bolagsstaemma-i-cell-impact/</loc>
                    <lastmod>2024-03-15T07:23:20&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-10-28-kallelse-till-extra-bolagsstaemma-i-cell-impact/</loc>
                    <lastmod>2024-03-15T07:23:19&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-10-28-styrelsen-i-cell-impact-avser-att-besluta-om-en-fullt-garanterad-foeretraedesemission-om-upp-till-cirka-350-miljoner-kronor/</loc>
                    <lastmod>2024-03-15T07:26:34&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-10-22-cell-impact-delaarsrapport-foer-tredje-kvartalet-fortsatt-stark-tillvaext/</loc>
                    <lastmod>2024-03-15T07:24:55&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-10-07-cell-impact-tidigarelaegger-delaarsrapport-foer-tredje-kvartalet/</loc>
                    <lastmod>2024-03-15T07:24:54&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-09-03-cell-impact-foerstaerker-ledningen-med-ny-hr-chef/</loc>
                    <lastmod>2024-03-15T07:26:33&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-08-25-cell-impact-delaarsrapport-foer-andra-kvartalet-2021-stark-tillvaext/</loc>
                    <lastmod>2024-03-15T07:24:53&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-08-09-kommunike-fraan-extra-bolagstaemma-i-cell-impact-ab/</loc>
                    <lastmod>2024-03-15T07:23:19&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-07-07-kallelse-till-extra-bolagsstaemma-i-cell-impact/</loc>
                    <lastmod>2023-06-21T11:25:07&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-07-05-cell-impact-japan-inc-faar-order-paa-5-3-miljoner-sek/</loc>
                    <lastmod>2024-03-15T07:26:32&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-05-12-cell-impact-foerstaerker-ledningen-med-ny-coo/</loc>
                    <lastmod>2023-06-07T08:44:59&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-05-12-cell-impact-foerstaerker-ledningen-med-ny-coo-1/</loc>
                    <lastmod>2023-06-07T08:44:59&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-05-07-cell-impact-delaarsrapport-foer-foersta-kvartalet-2021/</loc>
                    <lastmod>2024-03-15T07:24:52&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-04-22-kommunike-fraan-aarsstaemma-2021-i-cell-impact/</loc>
                    <lastmod>2024-03-15T07:23:17&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-03-31-cell-impact-japan-incs-kontor-nu-oeppnat/</loc>
                    <lastmod>2024-03-15T07:26:30&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-03-26-cell-impact-publicerar-aarsredovisning-foer-2020/</loc>
                    <lastmod>2024-03-15T07:24:59&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-03-19-kallelse-till-aarsstaemma-i-cell-impact/</loc>
                    <lastmod>2024-03-15T07:24:57&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-03-15-nowogen-technology-laegger-order-paa-1-3-msek-foer-serieproduktion-av-floedesplattor/</loc>
                    <lastmod>2024-03-15T07:26:29&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-03-12-cell-impact-faar-order-paa-42-miljoner-sek-fraan-plug-power-foer-ny-produktionslinje-och-floedesplattor/</loc>
                    <lastmod>2024-03-15T07:26:29&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-02-19-cell-impact-delaarsrapport-foer-fjaerde-kvartalet-2020/</loc>
                    <lastmod>2024-03-15T07:26:16&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2021-01-12-cell-impact-utnaemner-ny-chef-i-kina/</loc>
                    <lastmod>2024-03-15T07:26:28&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-12-03-cell-impact-annonserar-ny-strategi-i-japan/</loc>
                    <lastmod>2024-03-15T07:26:27&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-11-05-cell-impact-delaarsrapport-foer-tredje-kvartalet-2020/</loc>
                    <lastmod>2024-03-15T07:26:17&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-10-13-cell-impact-inviger-ny-fabrik-foer-floedesplattor-i-karlskoga/</loc>
                    <lastmod>2024-03-15T07:26:26&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-10-06-cell-impact-har-genomfoert-en-riktad-nyemission-om-175-miljoner-kronor/</loc>
                    <lastmod>2024-03-15T07:26:25&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-10-06-cell-impact-offentliggoer-avsikt-att-genomfoera-en-riktad-nyemission-om-cirka-7-miljoner-b-aktier/</loc>
                    <lastmod>2024-03-15T07:26:25&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-09-02-nowogen-technology-laegger-order-paa-produktion-av-floedesplattor/</loc>
                    <lastmod>2024-03-15T07:26:24&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-08-06-cell-impact-delaarsrapport-foer-andra-kvartalet-2020/</loc>
                    <lastmod>2023-06-21T11:26:54&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-08-04-positivt-slutresultat-av-hoegvolymtest/</loc>
                    <lastmod>2023-06-07T08:45:14&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-07-31-cell-impact-faar-ytterligare-order-paa-produktionsverktyg-foer-serieproduktion/</loc>
                    <lastmod>2023-06-07T08:45:14&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-07-15-cell-impact-faar-bestaellning-paa-produktionsverktyg/</loc>
                    <lastmod>2023-06-07T08:45:15&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-06-22-cell-impact-tillfoers-ytterligare-38-4-msek-genom-loesen-av-teckningsoptioner/</loc>
                    <lastmod>2023-06-07T08:45:16&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-06-10-paaminnelse-om-nyttjande-av-teckningsoptioner-av-serie-to-1-b/</loc>
                    <lastmod>2023-06-07T08:45:17&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-06-08-cell-impacts-huvudpatent-nu-beviljat-i-alla-maalmarknader/</loc>
                    <lastmod>2023-06-07T08:45:17&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-06-01-idag-inleds-nyttjandeperioden-foer-teckningsoptioner-to1b-i-cell-impact/</loc>
                    <lastmod>2023-06-07T08:45:18&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-05-07-cell-impact-delaarsrapport-januari-mars-2020/</loc>
                    <lastmod>2023-06-21T11:27:35&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-04-17-japanska-nkc-bestaeller-verktyg-och-floedesplattor-till-utvecklingsprojekt/</loc>
                    <lastmod>2023-06-07T08:45:20&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-04-16-kommunike-fraan-aarsstaemma-i-cell-impact/</loc>
                    <lastmod>2023-06-16T07:51:30&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-04-02-status-paa-hoegvolymtester-bestaellda-av-nkc/</loc>
                    <lastmod>2023-06-07T08:45:21&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-03-23-stefan-axellie-ny-cfo-foer-cell-impact/</loc>
                    <lastmod>2023-06-07T08:45:22&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-03-20-cell-impact-publicerar-aarsredovisning-foer-2019/</loc>
                    <lastmod>2023-06-21T12:20:23&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-03-16-kallelse-till-aarsstaemma-i-cell-impact/</loc>
                    <lastmod>2023-06-16T07:51:17&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-02-14-cell-impact-delaarsrapport-oktober-december-2019/</loc>
                    <lastmod>2023-06-21T12:21:32&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-01-21-cell-impact-uppdaterar-om-preliminaer-omsaettning-foer-2019/</loc>
                    <lastmod>2023-06-07T08:45:25&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-01-20-nkc-japan-laegger-bestaellning-paa-2-6-msek/</loc>
                    <lastmod>2023-06-07T08:45:26&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2020-01-17-cell-impact-och-nkc-japan-initierar-produktionstester-med-order-paa-1-8-msek/</loc>
                    <lastmod>2023-06-07T08:45:26&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-12-13-cell-impact-deltar-i-handelsdelegation-till-sydkorea/</loc>
                    <lastmod>2023-06-07T08:45:27&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-12-05-cell-impact-flyttar-till-ny-stoerre-produktionsanlaeggning/</loc>
                    <lastmod>2024-03-15T07:26:23&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-11-18-cell-impact-rekryterar-coo/</loc>
                    <lastmod>2024-03-15T07:26:22&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-11-05-cell-impact-delaarsrapport-juli-september-2019/</loc>
                    <lastmod>2023-06-21T11:31:10&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-10-15-cell-impact-faar-ny-order-fraan-japanska-nkc/</loc>
                    <lastmod>2023-06-07T08:45:30&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-10-02-cell-impact-faar-genombrottsorder-foer-serieproduktion-av-floedesplattor/</loc>
                    <lastmod>2023-06-07T08:45:31&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-09-02-cell-impact-erhaaller-vinnova-finansiering-foer-samarbete-med-rise-kring-framtidens-produktionsteknologi/</loc>
                    <lastmod>2024-03-15T07:26:21&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-08-29-cell-impact-och-japanska-nkc-foerstaerker-samarbetet/</loc>
                    <lastmod>2024-03-15T07:26:20&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-08-29-cell-impact-genomfoer-riktad-nyemission-om-cirka-5-msek/</loc>
                    <lastmod>2024-03-15T07:26:20&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-08-27-byte-av-certified-adviser-ca-till-fnca-sweden-ab/</loc>
                    <lastmod>2023-06-07T08:45:34&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-08-06-cell-impact-delaarsrapport-april-juni-2019/</loc>
                    <lastmod>2023-06-21T11:31:47&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-05-16-cell-impacts-emissioner-tillfoer-78-4-msek-foeretraedesemissionen-oevertecknades-med-239-procent/</loc>
                    <lastmod>2023-06-07T08:45:36&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-04-25-cell-impact-ab-offentliggoer-prospekt-i-samband-med-foeretraedesemission/</loc>
                    <lastmod>2023-06-07T08:45:37&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-04-23-cell-impact-delaarsrapport-januari-mars-2019/</loc>
                    <lastmod>2023-06-21T11:28:43&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-04-17-cell-impact-samarbetar-med-stor-japansk-underleverantoer-till-bilindustrin/</loc>
                    <lastmod>2024-03-15T07:26:19&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-04-11-kommunike-fraan-aarsstaemma-i-cell-impact/</loc>
                    <lastmod>2023-06-21T11:32:13&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-03-18-cell-impact-gaar-in-i-ny-fas-med-serietillverkning-av-nyutvecklad-floedesplatta-till-nordamerika/</loc>
                    <lastmod>2023-06-07T08:45:40&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-03-15-cell-impact-publicerar-aarsredovisning-foer-2018/</loc>
                    <lastmod>2023-06-21T12:22:37&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-03-12-raettelse-cell-impact-offentliggoer-fullt-saekerstaelld-foeretraedesemission-om-cirka-54-miljoner-kronor-riktad-emission-om-14-miljoner-kronor-samt-nya-finansiella-maal/</loc>
                    <lastmod>2023-06-07T08:45:41&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-03-11-cell-impact-aendrar-datum-foer-publicering-av-delaarsrapport-foer-foersta-kvartalet-2019/</loc>
                    <lastmod>2023-06-21T11:33:10&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-03-11-kallelse-till-aarsstaemma-i-cell-impact/</loc>
                    <lastmod>2023-06-21T11:33:25&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-03-11-cell-impact-offentliggoer-fullt-saekerstaelld-foeretraedesemission-om-cirka-54-miljoner-kronor-riktad-emission-om-14-miljoner-kronor-samt-nya-finansiella-maal/</loc>
                    <lastmod>2023-06-07T08:45:44&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2019-02-12-cell-impact-bokslutskommunike-2018/</loc>
                    <lastmod>2023-06-21T11:34:05&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-12-05-cell-impact-erhaaller-bryggfinansiering-paa-10-msek/</loc>
                    <lastmod>2023-06-07T08:45:45&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-11-27-cell-impact-faar-kinesisk-bestaellning-paa-floedesplattor/</loc>
                    <lastmod>2023-06-07T08:45:46&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-11-06-cell-impact-delaarsrapport-juli-september-2018/</loc>
                    <lastmod>2023-06-21T11:34:33&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-11-05-cell-impact-har-paaboerjat-en-kapitalanskaffningsprocess-och-har-foer-avsikt-att-genomfoera-en-riktad-emission/</loc>
                    <lastmod>2023-06-07T08:45:47&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-11-01-cell-impact-utser-ny-cto/</loc>
                    <lastmod>2024-06-04T05:57:06&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-10-30-cell-impact-goer-sin-foersta-rekrytering-i-kina/</loc>
                    <lastmod>2024-06-04T05:57:05&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-08-03-cell-impact-delaarsrapport-april-juni-2018/</loc>
                    <lastmod>2024-06-04T05:57:05&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-05-14-mats-svanberg-ny-cfo-paa-cell-impact/</loc>
                    <lastmod>2024-06-04T05:57:04&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-05-04-cell-impact-delaarsrapport-januari-mars-2018/</loc>
                    <lastmod>2024-06-04T05:57:03&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-05-02-ledningsfoeraendring-i-cell-impact/</loc>
                    <lastmod>2024-06-04T05:57:03&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-04-17-cell-impact-informerar-om-omvandling-av-bta-till-aktier/</loc>
                    <lastmod>2024-06-04T05:57:02&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-04-12-kommunike-fraan-cell-impacts-aarsstaemma-2018/</loc>
                    <lastmod>2024-06-04T05:57:01&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-03-20-utfall-i-nyemissioner-tillfoer-cell-impact-41-msek/</loc>
                    <lastmod>2024-06-04T05:57:00&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-03-12-cell-impact-kallar-till-aarsstaemma/</loc>
                    <lastmod>2024-06-04T05:57:00&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-03-09-vd-och-ledande-befattningshavare-tecknar-aktier-i-cell-impacts-paagaaende-nyemission/</loc>
                    <lastmod>2024-06-04T05:56:59&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-03-08-cell-impact-publicerar-aarsredovisning-foer-2017/</loc>
                    <lastmod>2024-06-04T05:56:58&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-02-28-cell-impact-faar-kinesisk-bestaellning-paa-egenutvecklad-floedesplatta/</loc>
                    <lastmod>2024-06-04T05:56:58&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-02-26-cell-impact-offentliggoer-prospekt-i-samband-med-foeretraedesemission/</loc>
                    <lastmod>2024-06-04T05:56:57&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-02-12-cell-impact-faar-bestaellning-paa-utvecklingsprojekt-av-floedesplattor/</loc>
                    <lastmod>2024-06-04T05:56:56&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-02-02-cell-impact-delaarsrapport-januari-december-2017/</loc>
                    <lastmod>2024-06-04T05:56:55&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-01-26-cell-impact-genomfoer-foeretraedesemission-saekerstaelld-till-85-samt-riktad-emission/</loc>
                    <lastmod>2024-06-04T05:56:54&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-01-12-cell-impact-foerstaerker-ledning-och-aktivitet-i-europa/</loc>
                    <lastmod>2024-06-04T05:56:53&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-01-08-cell-impact-faar-bestaellning-paa-egendesignade-floedesplattor/</loc>
                    <lastmod>2024-06-04T05:56:53&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2018-01-05-reservering-av-kundfoerluster-avseende-projekt-med-suzhou-china-hydrogen/</loc>
                    <lastmod>2024-06-04T05:56:52&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2017-12-27-cell-impact-faar-order-paa-utveckling-av-floedesplattor/</loc>
                    <lastmod>2024-06-04T05:56:51&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2017-10-27-delaarsrapport-1-januari-30-september-2017/</loc>
                    <lastmod>2024-06-04T05:56:50&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2017-09-07-cell-impact-informerar-om-vd-byte-och-fraan-maessan-i-beijing/</loc>
                    <lastmod>2024-06-04T05:56:50&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2017-08-16-cell-impact-erhaaller-kinesisk-order-paa-floedesplattor-till-braensleceller-foertydligande/</loc>
                    <lastmod>2024-06-04T05:56:49&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2017-08-16-cell-impact-erhaaller-kinesisk-order-paa-floedesplattor-till-braensleceller/</loc>
                    <lastmod>2024-06-04T05:56:48&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2017-07-21-delaarsrapport-1-januari-30-juni-2017/</loc>
                    <lastmod>2024-06-04T05:56:48&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2017-05-11-kommunike-fraan-aarsstaemma-i-cell-impact-den-11-maj-2017/</loc>
                    <lastmod>2024-06-04T05:56:47&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2017-04-28-delaarsrapport-1-januari-31-mars-2017/</loc>
                    <lastmod>2024-06-04T05:56:46&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2017-04-27-uppdatering-avseende-avtalsprocess-med-suzhou-china-hydrogen/</loc>
                    <lastmod>2024-06-04T05:56:45&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2017-04-10-kallelse-till-aarsstaemma-i-cell-impact/</loc>
                    <lastmod>2024-06-04T05:56:45&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2017-03-30-ytterligare-framsteg-foer-cell-impact-i-samarbetet-med-suzhou-china-hydrogen/</loc>
                    <lastmod>2024-06-04T05:56:44&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2017-03-27-valberedningens-sammansaettning-och-uppdrag/</loc>
                    <lastmod>2024-06-04T05:56:43&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2017-03-24-arsredovisning-foer-2016/</loc>
                    <lastmod>2024-06-04T05:56:43&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2017-03-20-cell-impacts-nya-produktionslina-aer-i-drift/</loc>
                    <lastmod>2024-06-04T05:56:42&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2017-03-10-cell-impact-rekryterar-ny-vd/</loc>
                    <lastmod>2024-06-04T05:56:41&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2017-03-06-ny-styrelseordfoerande-i-cell-impact/</loc>
                    <lastmod>2024-06-04T05:56:40&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2017-03-01-cell-impacts-styrelseordfoerande-jan-rynning-har-avlidit/</loc>
                    <lastmod>2024-06-04T05:56:40&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2017-01-27-delaarsrapport-1-januari-31-december-2016/</loc>
                    <lastmod>2024-06-04T05:56:39&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2017-01-19-cell-impact-erhaaller-order-som-viktig-milstolpe-mot-strategiskt-samarbete-med-kinesiskt-braenslecellsbolag/</loc>
                    <lastmod>2024-06-04T05:56:38&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2016-12-12-cell-impacts-emission-oevertecknad/</loc>
                    <lastmod>2024-06-04T05:56:38&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2016-11-22-offentliggoerande-av-prospekt-avseende-cell-impacts-foeretraedesemission/</loc>
                    <lastmod>2024-06-04T05:56:37&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2016-11-16-cell-impact-erhaaller-ramorder-fraan-kinesiskt-braenslecellsbolag/</loc>
                    <lastmod>2024-06-04T05:56:36&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2016-11-08-cell-impacts-foeretraedesmission-raettelse-kring-datum-samt-foertydligande-om-subsidiaer-foeretraedesraett/</loc>
                    <lastmod>2024-06-04T05:56:36&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2016-11-07-cell-impact-genomfoer-foeretraedesemission-om-50-4-msek-saekerstaelld-till-90/</loc>
                    <lastmod>2024-06-04T05:56:35&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2016-10-21-delaarsrapport-1-januari-30-september-2016/</loc>
                    <lastmod>2024-06-04T05:56:34&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2016-10-17-cell-impact-och-apt-tecknar-avsiktsfoerklaring-med-kinesiskt-braenslecellsbolag/</loc>
                    <lastmod>2024-06-04T05:56:33&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2016-09-26-cell-impact-erhaaller-bryggfinansiering-fraan-huvudaegare/</loc>
                    <lastmod>2024-06-04T05:56:33&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2016-07-15-delaarsrapport-1-januari-30-juni-2016/</loc>
                    <lastmod>2024-06-04T05:56:32&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2016-06-28-cell-impact-erhaaller-order-fraan-global-fordonstillverkare/</loc>
                    <lastmod>2024-06-04T05:56:31&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2016-05-13-kommunike-fraan-aarsstaemma-i-cell-impact-den-12-maj-2016/</loc>
                    <lastmod>2024-06-04T05:56:31&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2016-04-22-delaarsrapport-1-januari-31-mars-2016/</loc>
                    <lastmod>2024-06-04T05:56:30&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2016-04-11-kallelse-till-aarsstaemma-i-cell-impact/</loc>
                    <lastmod>2024-06-04T05:56:29&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2016-04-11-cell-impact-foereslaar-val-av-ny-styrelseledamot/</loc>
                    <lastmod>2024-06-04T05:56:29&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2016-04-08-cell-impact-erhaaller-order-paa-ca-en-halv-miljon-kronor/</loc>
                    <lastmod>2024-06-04T05:56:28&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2016-03-21-arsredovisning-foer-2015/</loc>
                    <lastmod>2024-06-04T05:56:27&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2016-03-15-cell-impact-rapporterar-om-organisationsfoeraendringar-och-fraan-fuel-cell-expo-i-tokyo/</loc>
                    <lastmod>2024-06-04T05:56:27&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2016-02-10-valberedningen-har-konstituerats/</loc>
                    <lastmod>2024-06-04T05:56:26&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2016-01-29-delaarsrapport-1-januari-31-december-2015/</loc>
                    <lastmod>2024-06-04T05:56:25&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2016-01-12-cell-impact-tecknar-kommersiellt-utvecklingsavtal-med-global-marknadsledare-inom-ett-nytt-industriellt-segment/</loc>
                    <lastmod>2024-06-04T05:56:24&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-12-30-cell-impact-beslutar-om-riktad-nyemission/</loc>
                    <lastmod>2024-06-04T05:56:23&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-12-22-kommunike-fraan-extra-bolagsstaemma-den-22-december-2015-i-cell-impact/</loc>
                    <lastmod>2024-06-04T05:56:23&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-12-17-foeraendring-i-ledningen-paa-cell-impact/</loc>
                    <lastmod>2024-06-04T05:56:22&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-12-08-cell-impact-har-faatt-patent-beviljat/</loc>
                    <lastmod>2024-06-04T05:56:21&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-12-03-cell-impact-kallar-till-extra-bolagsstaemma/</loc>
                    <lastmod>2024-06-04T05:56:20&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-11-24-cell-impact-rapporterar-fraan-fuel-cell-seminar/</loc>
                    <lastmod>2024-06-04T05:56:20&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-11-18-raettelse-delaarsrapport-januari-september-2015/</loc>
                    <lastmod>2024-06-04T05:56:19&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-10-23-delaarsrapport-1-januari-30-september-2015/</loc>
                    <lastmod>2024-06-04T05:56:18&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-10-22-cell-impact-beviljas-almis-tillvaextlaan-foer-innovativa-foeretag/</loc>
                    <lastmod>2024-06-04T05:56:17&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-10-14-cell-impact-faar-order-paa-floedesplattor-till-braensleceller/</loc>
                    <lastmod>2024-06-04T05:56:17&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-09-01-cell-impact-foerlaenger-utvecklingsavtalet-med-den-expansiva-aktoeren/</loc>
                    <lastmod>2024-06-04T05:56:16&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-07-17-cell-impact-delaarsrapport-1-januari-30-juni-2015/</loc>
                    <lastmod>2024-06-04T05:56:15&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-06-03-cell-impact-i-samarbete-foer-effektivare-tillverkning-av-braenslecellsplattor/</loc>
                    <lastmod>2024-06-04T05:56:14&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-05-07-kommunike-fraan-aarsstaemma-i-cell-impact-den-7-maj-2015/</loc>
                    <lastmod>2024-06-04T05:56:13&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-04-24-delaarsrapport-1-januari-31-mars-2015/</loc>
                    <lastmod>2024-06-04T05:56:13&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-04-01-kallelse-till-aarsstaemma/</loc>
                    <lastmod>2024-06-04T05:56:12&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-03-27-arsredovisning-foer-2014/</loc>
                    <lastmod>2024-06-04T05:56:11&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-03-26-cell-impact-byter-certified-adviser/</loc>
                    <lastmod>2024-06-04T05:56:10&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-03-05-apt-och-cell-impact-tecknar-samarbetsavtal-kring-hoeghastighetsbockning/</loc>
                    <lastmod>2024-06-04T05:56:09&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-01-30-bokslutskommunike-1-januari-31-december-2014/</loc>
                    <lastmod>2024-06-04T05:56:09&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2015-01-02-cell-impact-foerlaenger-kommersiellt-utvecklingsavtal-med-braenslecellsaktoer/</loc>
                    <lastmod>2024-06-04T05:56:08&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2014-05-15-kommunike-fraan-aarsstaemma/</loc>
                    <lastmod>2024-06-04T05:56:07&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2014-05-08-cell-impact-foerlaenger-kommersiellt-utvecklingsavtal-med-braenslecellsaktoer/</loc>
                    <lastmod>2024-06-04T05:56:06&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2014-04-15-kallelse-till-aarsstaemma-i-cell-impact/</loc>
                    <lastmod>2024-06-04T05:56:06&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2014-01-08-cell-impact-foerlaenger-kommersiellt-utvecklingsavtal-med-braenslecellsaktoer/</loc>
                    <lastmod>2024-06-04T05:56:05&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2013-12-09-cell-impacts-foeretraedesemission-oevertecknad/</loc>
                    <lastmod>2024-06-04T05:56:04&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2013-11-28-valberedningen-i-cell-impact-har-konstituerats/</loc>
                    <lastmod>2024-06-04T05:56:03&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2013-11-20-cell-impact-bjuder-in-till-informationstraeff-med-anledning-av-paagaaende-nyemission/</loc>
                    <lastmod>2024-06-04T05:56:03&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2013-11-11-offentliggoer-prospekt-avseende-foeretraedesemission/</loc>
                    <lastmod>2024-06-04T05:56:02&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2013-11-08-trading-in-subscription-rights-tr-and-subscription-shares-bta-in-cell-impact/</loc>
                    <lastmod>2024-06-04T05:56:01&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2013-10-30-genomfoer-foeretraedesemission-om-14-msek/</loc>
                    <lastmod>2024-06-04T05:56:01&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2013-10-18-kommunike-fraan-extra-bolagsstaemma-korrigerad-pdf/</loc>
                    <lastmod>2024-06-04T05:56:00&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2013-10-08-tidigarelaegger-rapport-foer-tredje-kvartalet/</loc>
                    <lastmod>2024-06-04T05:55:59&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2013-10-04-kallelse-till-extra-bolagsstaemma/</loc>
                    <lastmod>2024-06-04T05:55:59&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2013-10-04-kallar-till-extra-bolagsstaemma-den-18-oktober/</loc>
                    <lastmod>2024-06-04T05:55:58&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2013-09-30-foerlaenger-kommersiellt-utvecklingsavtal-med-braenslecellsaktoer/</loc>
                    <lastmod>2024-06-04T05:55:57&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2013-04-24-kommunike-fraan-aarsstaemma/</loc>
                    <lastmod>2024-06-04T05:55:56&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2013-04-16-kallelse-till-aarsstaemma/</loc>
                    <lastmod>2024-06-04T05:55:56&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2013-03-15-undertecknar-kommersiellt-utvecklingsavtal-med-braenslecellsaktoer/</loc>
                    <lastmod>2024-06-04T05:55:55&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2013-02-20-nasdaq-omx-welcomes-cell-impact-to-first-north/</loc>
                    <lastmod>2024-06-04T05:55:54&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2013-02-15-cell-impact-upptas-till-handel-paa-first-north/</loc>
                    <lastmod>2024-06-04T05:55:53&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-07-03-extrem-maetprecision-ger-cell-impact-foerutsaettningar-att-baettre-stoedja-kundernas-produktutveckling/</loc>
                    <lastmod>2023-07-03T09:44:37&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-07-13-cell-impact-initierar-ett-besparingsprogram-foer-att-moeta-ett-foervaentat-minskat-infloede-av-ordrar/</loc>
                    <lastmod>2023-07-13T06:00:46&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-08-24-cell-impact-q2-2023-tillfaelligt-laegre-aktivitet-och-besparingsprogram/</loc>
                    <lastmod>2023-08-24T06:01:52&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-08-30-stort-kommersiellt-intresse-foer-cell-impact-forming-i-japan/</loc>
                    <lastmod>2024-03-15T07:25:16&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-09-05-cell-impact-deltar-i-vaetgasmaessan-h2-meet-paa-kintex-sydkorea/</loc>
                    <lastmod>2023-09-05T14:16:43&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-09-06-cell-impact-deltar-hy-fcell-konferens-och-utstaellning-i-stuttgart/</loc>
                    <lastmod>2023-10-18T09:35:27&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-09-29-styrelseledamot-i-cell-impact-laemnar-paa-egen-begaeran/</loc>
                    <lastmod>2023-09-29T06:58:12&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-10-04-cell-impact-har-faatt-en-order-fraan-plug-power-vaerd-22-0-msek/</loc>
                    <lastmod>2023-10-04T06:00:29&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-10-04-cell-impact-offentliggoer-operationell-uppdatering-meddelar-preliminaera-foersaeljningssiffror-och-kommer-att-kalla-till-extra-bolagsstaemma-foer-att-skapa-flexibilitet-i-foerestaaende-kapitalanskaffning/</loc>
                    <lastmod>2023-10-04T06:05:27&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-10-04-kallelse-till-extra-bolagsstaemma-i-cell-impact-ab-publ/</loc>
                    <lastmod>2023-10-09T14:35:08&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-10-23-styrelsen-i-cell-impact-avser-att-besluta-om-en-foeretraedesemission-om-upp-till-cirka-152-miljoner-kronor-och-meddelar-preliminaert-roerelseresultat-foer-q3-2023/</loc>
                    <lastmod>2023-10-23T15:35:08&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-11-03-cell-impact-q3-2023-laag-efterfraagan-men-fortsatt-stort-intresse/</loc>
                    <lastmod>2023-11-03T07:02:46&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-11-03-kommunike-fraan-extra-bolagsstaemma-i-cell-impact-ab-publ/</loc>
                    <lastmod>2024-03-15T07:25:09&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-11-08-styrelsen-i-cell-impact-har-beslutat-om-den-tidigare-aviserade-foeretraedesemissionen-om-upp-till-cirka-152-miljoner-kronor/</loc>
                    <lastmod>2023-11-08T18:31:20&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-11-15-cell-impact-offentliggoer-prospekt-avseende-foeretraedesemissionen/</loc>
                    <lastmod>2024-03-15T07:25:07&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-12-06-cell-impact-offentliggoer-slutgiltigt-utfall-i-bolagets-delvis-garanterade-foeretraedesemission/</loc>
                    <lastmod>2024-03-22T08:57:22&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-12-13-stefan-axellie-laemnar-rollen-som-cfo-foer-cell-impact-ab/</loc>
                    <lastmod>2024-03-22T09:02:51&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-12-18-foersta-dag-foer-handel-med-teckningsoptioner-av-serie-20232024-to2/</loc>
                    <lastmod>2024-03-22T08:48:50&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2023-12-20-paer-teike-laemnar-rollen-som-ceo-paa-cell-impact-ab/</loc>
                    <lastmod>2024-03-22T09:02:21&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-01-17-malin-lundberg-tilltraeder-som-cfo-paa-cell-impact-ab/</loc>
                    <lastmod>2024-03-22T08:35:50&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-02-16-cell-impact-q4-2023-foervaentat-svagt-kvartal-men-saekrad-finansiering/</loc>
                    <lastmod>2024-06-04T06:01:40&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-03-08-cell-impact-faar-order-vaerd-18-miljoner-inom-elektrolysomraadet/</loc>
                    <lastmod>2024-03-22T08:36:34&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-03-15-cell-impact-moeter-foeretraedare-foer-vaetgasbranschen-i-usa/</loc>
                    <lastmod>2024-03-15T07:03:19&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-03-22-cell-impact-publicerar-aarsredovisning-foer-2023/</loc>
                    <lastmod>2024-03-25T16:07:40&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-03-22-kallelse-till-aarsstaemma-i-cell-impact-ab-publ/</loc>
                    <lastmod>2024-03-22T13:59:16&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-04-25-kommunike-fraan-aarsstaemman-2024-i-cell-impact-ab-publ/</loc>
                    <lastmod>2024-04-25T14:56:04&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-04-26-cell-impact-har-tecknat-avtal-om-leveranser-till-ett-vaerde-av-3-2-msek/</loc>
                    <lastmod>2024-04-26T11:00:26&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-05-06-cell-impact-och-fcc-japan-i-foerlaengt-samarbete/</loc>
                    <lastmod>2024-05-06T10:07:00&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-05-06-cell-impact-tecknar-ramavtal-med-fcc/</loc>
                    <lastmod>2024-06-04T05:53:21&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-05-14-cell-impact-q1-2024-laegger-grunden-foer-leveranser-i-stor-volym/</loc>
                    <lastmod>2024-06-04T05:51:14&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-07-01-cell-impact-ska-utveckla-och-leverera-ett-prototypverktyg-till-en-ledande-europeisk-industriell-leverantoer/</loc>
                    <lastmod>2024-07-01T06:43:27&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-07-03-cell-impact-adderar-ny-taetningsteknik-som-del-i-produktionsprocessen/</loc>
                    <lastmod>2024-07-03T07:21:40&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-07-11-cell-impact-har-tilldelats-silvermedalj-av-ecovadis/</loc>
                    <lastmod>2024-07-11T13:01:19&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-07-26-cell-impact-och-fcc-tar-samarbetet-till-naesta-nivaa/</loc>
                    <lastmod>2024-07-26T10:21:29&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-08-23-cell-impact-q2-2024-nya-kunder-och-stigande-omsaettning/</loc>
                    <lastmod>2024-08-23T06:07:13&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-09-10-cell-impacts-styrelse-har-utsett-ordinarie-vd-foer-bolaget/</loc>
                    <lastmod>2024-09-10T06:03:19&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-09-16-teckningskursen-foer-utnyttjande-av-teckningsoptioner-av-serie-20232024-to2-i-cell-impact-har-faststaellts-till-0-17-sek-och-teckningsperioden-inleds-idag/</loc>
                    <lastmod>2024-09-16T08:38:19&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-09-25-sista-dag-foer-handel-med-teckningsoptionerna-av-serie-20232024-to2/</loc>
                    <lastmod>2024-09-25T06:03:22&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-09-27-cell-impact-foerstaerker-produktionskapacitet-genom-avtal-med-andritz-soutec-ag/</loc>
                    <lastmod>2024-09-27T06:03:24&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-10-01-cell-impact-offentliggoer-utfall-i-utnyttjandet-av-teckningsoptioner-av-serie-20232024-to2/</loc>
                    <lastmod>2024-10-01T14:45:16&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-10-22-cell-impact-har-tecknat-avtal-om-leverans-av-floedesplattor-i-titan/</loc>
                    <lastmod>2024-10-22T11:34:22&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-11-06-cell-impact-q3-2024-fortsatt-utveckling-av-produktionskapaciteten/</loc>
                    <lastmod>2024-11-06T07:07:13&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2024-12-11-cell-impact-beraettar-under-vaetgaskonferens-om-hur-groen-vaetgas-kan-skalas-upp/</loc>
                    <lastmod>2024-12-11T07:48:37&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-02-06-cell-impact-deltar-i-decarbonization-expo-2025-i-tokyo/</loc>
                    <lastmod>2025-02-06T09:05:53&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-02-14-cell-impact-q4-2024-vael-rustade-naer-marknaden-tar-fart/</loc>
                    <lastmod>2025-02-14T07:05:30&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-03-20-cell-impact-publicerar-aarsredovisning-foer-2024/</loc>
                    <lastmod>2025-03-20T07:03:58&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-03-20-kallelse-till-arsstamma-i-cell-impact-ab-publ/</loc>
                    <lastmod>2025-03-20T07:11:19&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-04-10-cell-impact-intensifierar-arbetet-med-finansiering-foer-att-kunna-foerverkliga-bolagets-marknadspotential/</loc>
                    <lastmod>2025-04-10T14:33:10&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-04-24-kommunike-fraan-aarsstaemman-2025-i-cell-impact-ab-publ/</loc>
                    <lastmod>2025-04-24T14:46:48&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-05-14-cell-impact-q1-2025-intensifierar-arbetet-med-att-soeka-finansiering/</loc>
                    <lastmod>2025-05-14T06:04:11&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-05-19-cell-impact-levererar-floedesplattor-och-testverktyg-till-en-betydande-aktoer-i-asien/</loc>
                    <lastmod>2025-05-19T06:03:16&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-05-20-cell-impact-beslutar-om-en-foeretraedesemission-om-cirka-62-7-msek-samt-upptar-brygglaan/</loc>
                    <lastmod>2025-05-20T07:48:32&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-05-20-kallelse-till-extra-bolagsstamma-i-cell-impact-ab-publ/</loc>
                    <lastmod>2025-05-20T07:48:09&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-06-19-kommunike-fraan-extra-bolagsstaemma-i-cell-impact-ab-publ/</loc>
                    <lastmod>2025-06-19T10:00:56&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-06-25-cell-impact-offentliggoer-informationsdokument-avseende-foeretraedesemission/</loc>
                    <lastmod>2025-06-25T08:00:26&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-07-14-cell-impact-offentliggoer-utfall-i-foeretraedesemission/</loc>
                    <lastmod>2025-07-14T13:50:24&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-07-18-cell-impact-genomfoer-riktade-emissioner-av-aktier-och-teckningsoptioner-till-emissionsgaranter/</loc>
                    <lastmod>2025-07-18T15:15:23&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-07-23-sista-dag-foer-handel-med-bta-i-cell-impact-omvandling-av-bta-till-aktier/</loc>
                    <lastmod>2025-07-23T12:36:33&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-08-18-sammanlaeggning-av-aktier-i-cell-impact-ab-publ/</loc>
                    <lastmod>2025-08-18T12:25:52&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-08-22-cell-impact-q2-2025-saekrad-finansiering-foer-verksamheten/</loc>
                    <lastmod>2025-08-22T06:05:52&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-10-02-cell-impact-inleder-kontinuerlig-produktion-foer-nordamerikansk-kund/</loc>
                    <lastmod>2025-10-02T11:45:52&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-11-06-cell-impact-q3-2025-redo-att-vaexla-upp-foer-kommande-affaerer/</loc>
                    <lastmod>2025-11-06T07:04:00&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-11-06-cell-impact-i-samarbetsavtal-med-thyssenkrupp-automotion-engineering/</loc>
                    <lastmod>2025-11-06T10:54:38&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-11-11-cell-impact-har-tilldelats-guldmedalj-av-ecovadis/</loc>
                    <lastmod>2025-11-11T12:41:20&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-11-21-cell-impact-utsedd-till-aarets-tillverkare-av-floedesplattor/</loc>
                    <lastmod>2025-11-21T08:56:25&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-12-09-cell-impact-levererar-verktyg-till-ledande-fordonstillverkare/</loc>
                    <lastmod>2025-12-09T12:12:25&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-12-22-cell-impact-beslutar-om-en-foeretraedesemission-om-cirka-38-3-msek-upptar-brygglaan-och-diversifierar-verksamheten-mot-fler-industrisegment/</loc>
                    <lastmod>2025-12-22T17:20:28&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2025-12-22-kallelse-till-extra-bolagsstaemma-i-cell-impact-ab-publ/</loc>
                    <lastmod>2026-01-14T08:37:54&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2026-01-30-kommunike-fraan-extra-bolagsstaemma-i-cell-impact-ab-publ/</loc>
                    <lastmod>2026-01-30T12:02:57&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2026-02-04-cell-impact-q4-2025-tillvaext-och-breddning-av-verksamheten-aer-vaegen-framaat/</loc>
                    <lastmod>2026-02-04T07:05:14&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2026-02-05-cell-impact-offentliggoer-informationsdokument-avseende-foeretraedesemission/</loc>
                    <lastmod>2026-02-05T12:17:38&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2026-02-24-cell-impact-offentliggoer-utfall-i-foeretraedesemission/</loc>
                    <lastmod>2026-02-24T15:40:26&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2026-02-25-cell-impact-i-ersaettningsavtal-erhaaller-6-msek/</loc>
                    <lastmod>2026-02-25T07:41:03&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2026-03-04-cell-impact-genomfoer-riktad-emission-av-aktier-till-emissionsgaranter-samt-riktad-emission-av-teckningsoptioner-till-laangivare/</loc>
                    <lastmod>2026-03-04T16:58:45&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2026-03-06-sista-dag-foer-handel-med-bta-i-cell-impact-omvandling-av-bta-till-aktier/</loc>
                    <lastmod>2026-03-06T15:21:29&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.9</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2026-03-20-cell-impact-publicerar-aarsredovisning-foer-2025/</loc>
                    <lastmod>2026-03-20T09:30:10&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/pressmeddelanden/2026-03-20-kallelse-till-arsstamma-i-cell-impact-ab-publ/</loc>
                    <lastmod>2026-03-20T07:11:04&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/prenumerera/</loc>
                    <lastmod>2023-06-26T08:51:16&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/media/bildarkiv/</loc>
                    <lastmod>2024-01-04T08:09:34&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/kontakt/</loc>
                    <lastmod>2024-02-12T08:26:43&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
                <url>
                    <loc>https://investor.cellimpact.com/mallsida/</loc>
                    <lastmod>2023-04-27T09:48:59&#x2B;00:00</lastmod>
                    <changefreq>daily</changefreq>
                    <priority>0.5</priority>
                </url>
    </urlset>

